Trexquant Investment LP Merrimack Pharmaceuticals Inc Transaction History

Trexquant Investment LP

  • $7.59 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 07, 2018
SELL
$3.86 - $7.61 $67,654 - $133,380
-17,527 Closed
0 $0
Q1 2018

May 03, 2018
SELL
$6.24 - $9.15 $23,836 - $34,953
-3,820 Reduced 17.89%
17,527 $141,000
Q4 2017

Feb 09, 2018
BUY
$7.99 - $11.87 $170,562 - $253,388
21,347
21,347 $219,000

Others Institutions Holding MACK

# of Institutions
2
Shares Held
349
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email